Latest News

03.22.19

Novartis Plans for Alcon Spin-Off on April 9, 2019

Source: Novartis

03.13.19

National Cancer Institute Director Ned Sharpless to Become Acting FDA Head

Source: FirstWord

03.08.19

Gottlieb’s Quick Goodbye Triggers Investor Panic, Biopharma Bewilderment

Source: FiercePharma

03.06.19

Raindrop Near Vision Inlay Recalled

Source: Eyewire News

03.05.19

FDA Chief Scott Gottlieb to Resign

Source: Bloomberg

03.04.19

Biogen to Acquire Gene Therapy Company Nightstar Therapeutics

Source: Biogen

03.01.19

Survey: Physicians Generate an Average of $2.4 Million a Year Per Hospital

Source: Merritt Hawkins

02.27.19

Pharmaceutical Executives Field Questions at US Senate Hearing Over Drug Pricing

Source: FirstWord

02.26.19

Novartis Issues Summary Financial Information for the Alcon Eye Care Business Ahead of Shareholder Vote

Source: Novartis

02.25.19

Roche Acquires Spark Therapeutics in $4.8 Billion Deal

Source: Roche

View more stories